The European Commission (EC) emphasized on Wednesday that the regions of the European Union (EU) Can buy vaccines that are not part of the community strategy Injection, such as Russian Sputnik V, depends on the institutional framework of each member state.
After learning about the Madrid Autonomous Region, Brussels has already expressed its views in this regard. Started the conversation two months ago Reached a pre-purchase agreement with Sputnik V supplier.
“If the vaccine is not part of the EU vaccine portfolio, the member states They can decide to buy.Is the area available Depends on the institutional structure The European Community Health Spokesperson Stefan de Keersmaecker announced to Efe.
In this sense, he explained that the vaccine policy This is the capacity of member states And apply the norms and “institutional arrangements” of the countries involved.
Similarly, it clearly stipulates that if injections are part of the EU product portfolio, the European Commission does not allow parallel negotiations or contracts with pharmaceutical companies Responsible for purchasing and distributing vaccines Between Member States.
Currently, the European Medicines Agency has authorized the use of Four shots at the community club: The European Union has also signed contracts with the pharmaceutical companies of Pfizer-BioNTech, Moderna, AstraZeneca and Janssen.
In addition, Brussels has signed a contract with the laboratory Sanofi GSK and CureVac, Although its vaccine has not yet been approved by the European Medicines Agency (EMA).
However, the committee No promise to get a dose of Russian Sputnik V, It is not part of its injection product portfolio, nor is it approved by EMA. Nevertheless, member states like Hungary have acquired it themselves and are managing their citizens.
The Madrid Ministry of Health and the representatives of Sputnik V discussed Reach a preliminary agreement ABC announced on Tuesday that in order to obtain authorization from the European Medicines Agency, it would make beneficial purchases “for the entire national health system” to “give time for negotiation.” The source of the department also confirmed to Efe.
EMA has confirmed on Wednesday that it will conduct a “good clinical practice check” on the way volunteers of the “Sputnik V” vaccine will be tested in Russia, and the procedure is under continuous review. This regulator.